Recurrent Glioma Clinical Trials

34 clinical trials for Recurrent Glioma across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial — RECRUITING · NA
• Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma — RECRUITING · PHASE1
• CARv3-TEAM-E T Cells in Glioblastoma — RECRUITING · PHASE1
• Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment — RECRUITING · PHASE2
• Sitagliptin in Recurrent/Progressive Grade 4 Glioma — RECRUITING · PHASE1
• PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial — RECRUITING · NA
• A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors — RECRUITING · PHASE1
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases — TERMINATED · PHASE1
• Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Niraparib In Recurrent IDH 1/2 Gliomas — ACTIVE_NOT_RECRUITING · PHASE1
• Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations — ACTIVE_NOT_RECRUITING · PHASE2
• Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors — NOT_YET_RECRUITING · PHASE1
• Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients — WITHDRAWN · NA
• Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) — COMPLETED · PHASE2
• Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) — COMPLETED · PHASE2
• Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) — COMPLETED · PHASE2
• Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd — COMPLETED · PHASE2
• PARP Inhibition for Gliomas (PI-4G or π4g) — TERMINATED · PHASE2
• Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors — TERMINATED · PHASE1
• Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) — ACTIVE_NOT_RECRUITING · PHASE3
• Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) — COMPLETED · PHASE2
• Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. — OTHER · NA
• A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas — COMPLETED · PHASE1
• Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence — OTHER · PHASE2
• Personalized Vaccine for Patients With Recurrent Malignant Glioma — OTHER · PHASE1
• Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas — OTHER
• Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome — OTHER
• Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma — COMPLETED · PHASE1
• Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme — OTHER · PHASE2

Refine this search